Abstract
Japanese encephalitis virus, a neurotropic flavivirus, causes sporadic encephalitis with nearly 25% fatal case reports. JEV infects neural stem/progenitor cells (NSPCs) and decreases their proliferation. Statin, a commonly used class of cholesterol lowering drug, has been shown to possess potent anti-inflammatory and neuroprotective effects in acute brain injury and chronic neurodegenerative conditions. Here, we aimed to check the efficacy of atorvastatin in alleviating the symptoms of Japanese encephalitis (JE). Using BALB/c mouse model of JEV infection, we observed that atorvastatin effectively reduces viral load in the subventricular zone (SVZ) of infected pups and decreases the resultant cell death. Furthermore, atorvastatin abrogates microglial activation and production of proinflammatory cyto/chemokine production post JEV infection in vivo. It also reduced interferon-β response in the neurogenic environs. The neuroprotective role of atorvastatin is again evident from the rescued neurosphere size and decreased cell death in vitro. It has also been observed that upon atorvastatin administration, cell cycle regulatory proteins and cell survival proteins are also restored to their respective expression level as observed in uninfected animals. Thus the antiviral, immunomodulatory and neuroprotective roles of atorvastatin reflect in our experimental observations. Therefore, this drug broadens a path for future therapeutic measures against JEV infection.
Similar content being viewed by others
Abbreviations
- ATR:
-
atorvastatin
- JEV:
-
Japanese encephalitis virus
- NSPC:
-
neural stem/progenitor cell
References
Abrous DN, Koehl M and Le Moal M 2005 Adult neurogenesis: from precursors to network and physiology. Physiol. Rev. 85 523–569
Aktas O, Waiczies S, Smorodchenko A, Dorr J, Seeger B et al. 2003 Treatment of relapsing paralysis in experimental encephalomyelitis by targeting Th1 cells through atorvastatin. J. Exp. Med. 197 725–733
Amarenco P, Bogousslavsky J, Callahan A, 3rd, Goldstein LB, Hennerici M et al. 2006 High-dose atorvastatin after stroke or transient ischemic attack. N. Engl. J. Med. 355 549–559
Arvidsson A, Collin T, Kirik D, Kokaia Z and Lindvall O 2002 Neuronal replacement from endogenous precursors in the adult brain after stroke. Nat. Med. 8 963–970
Basu A and Dutta K 2017 Recent advances in Japanese encephalitis. F1000Res 6 259
Borsini A, Zunszain PA, Thuret S and Pariante CM 2015 The role of inflammatory cytokines as key modulators of neurogenesis. Trends Neurosci. 38 145–157
Cacci E, Claasen JH and Kokaia Z 2005 Microglia-derived tumor necrosis factor-alpha exaggerates death of newborn hippocampal progenitor cells in vitro. J. Neurosci. Res. 80 789–797
Chang JR, Ghafouri M, Mukerjee R, Bagashev A, Chabrashvili T et al. 2012 Role of p53 in neurodegenerative diseases. Neurodegener. Dis. 9 68–80
Chataway J, Schuerer N, Alsanousi A, Chan D, MacManus D, et al. 2014 Effect of high-dose simvastatin on brain atrophy and disability in secondary progressive multiple sclerosis (MS-STAT): a randomised, placebo-controlled, phase 2 trial. Lancet 383 2213–2221
Chen J, Zacharek A, Li A, Cui X, Roberts C et al. 2008 Atorvastatin promotes presenilin-1 expression and Notch1 activity and increases neural progenitor cell proliferation after stroke. Stroke 39 220–226
Chen J, Zhang ZG, Li Y, Wang Y, Wang L et al. 2003 Statins induce angiogenesis, neurogenesis, and synaptogenesis after stroke. Ann. Neurol. 53 743–751
Choi NY, Kim JY, Hwang M, Lee EH, Choi H et al. 2019 Atorvastatin rejuvenates neural stem cells injured by oxygen-glucose deprivation and induces neuronal differentiation through activating the PI3K/Akt and ERK pathways. Mol. Neurobiol. 56 2964–2977
Crosse KM, Monson EA, Beard MR and Helbig KJ 2018 Interferon-stimulated genes as enhancers of antiviral innate immune signaling. J. Innate. Immun. 10 85–93
Das S and Basu A 2008 Japanese encephalitis virus infects neural progenitor cells and decreases their proliferation. J. Neurochem. 106 1624–1636
Das S, Dutta K, Kumawat KL, Ghoshal A, Adhya D et al. 2011 Abrogated inflammatory response promotes neurogenesis in a murine model of Japanese encephalitis. PLoS One 6 e17225
Dufek M, Rektorova I, Thon V, Lokaj J and Rektor I 2015 Interleukin-6 May contribute to mortality in Parkinson’s disease patients: a 4-year prospective study. Parkinsons Dis. 2015 898192
Ekdahl CT, Claasen JH, Bonde S, Kokaia Z and Lindvall O 2003 Inflammation is detrimental for neurogenesis in adult brain. Proc. Natl. Acad. Sci. USA 100 13632–13637
Feng X, Han D, Kilaru BK, Franek BS, Niewold TB, et al. 2012 Inhibition of interferon-beta responses in multiple sclerosis immune cells associated with high-dose statins. Arch. Neurol. 69 1303–1309
Fusaro G, Dasgupta P, Rastogi S, Joshi B and Chellappan S 2003 Prohibitin induces the transcriptional activity of p53 and is exported from the nucleus upon apoptotic signaling. J. Biol. Chem. 278 47853–47861
Ghoshal A, Das S, Ghosh S, Mishra MK, Sharma V et al. 2007 Proinflammatory mediators released by activated microglia induces neuronal death in Japanese encephalitis. Glia 55 483–496
Göritz C and Frisén J 2012 Neural stem cells and neurogenesis in the adult. Cell. Stem. Cell. 10 657–659
Iosif RE, Ekdahl CT, Ahlenius H, Pronk CJ, Bonde S et al. 2006 Tumor necrosis factor receptor 1 is a negative regulator of progenitor proliferation in adult hippocampal neurogenesis. J. Neurosci. 26 9703–9712
Ishikawa T and Konishi E 2015 Potential chemotherapeutic targets for Japanese encephalitis: current status of antiviral drug development and future challenges. Expert. Opin. Ther. Targets. 19 1379–1395
Kumar R, Basu A, Sinha S, Das M, Tripathi P et al. 2016 Role of oral Minocycline in acute encephalitis syndrome in India - a randomized controlled trial. BMC Infect. Dis. 16 67
Kumar R, Tripathi P, Baranwal M, Singh S, Tripathi S et al. 2009 Randomized, controlled trial of oral ribavirin for Japanese encephalitis in children in Uttar Pradesh, India. Clin. Infect. Dis. 48 400–406
Lee SH, Choi NY, Yu HJ, Park J, Choi H et al. 2016 Atorvastatin protects NSC-34 motor neurons against oxidative stress by activating PI3K, ERK and free radical scavenging. Mol. Neurobiol. 53 695–705
Liu Z, Pelfrey CM, Cotleur A, Lee JC and Rudick RA 2001 Immunomodulatory effects of interferon beta-1a in multiple sclerosis. J. Neuroimmunol. 112 153–162
Lum M, Croze E, Wagner C, McLenachan S, Mitrovic B et al. 2009 Inhibition of neurosphere proliferation by IFNgamma but not IFNbeta is coupled to neuronal differentiation. J. Neuroimmunol. 206 32–38
Ma DK, Bonaguidi MA, Ming GL and Song H 2009 Adult neural stem cells in the mammalian central nervous system. Cell Res. 19 672–682
Mallick S, Chakraborty S, Hazra B, Dev S, Mukherjee S et al. 2019 Novel strategy for treating neurotropic viral infections using hypolipidemic drug Atorvastatin. bioRxiv https://doi.org/10.1101/639096639096
Marti-Fabregas J, Romaguera-Ros M, Gomez-Pinedo U, Martinez-Ramirez S, Jimenez-Xarrie E, et al. 2010 Proliferation in the human ipsilateral subventricular zone after ischemic stroke. Neurology 74 357–365
Martino G, Butti E and Bacigaluppi M 2014 Neurogenesis or non-neurogenesis: that is the question. J. Clin. Invest. 124 970–973
Mehrbod P, Omar AR, Hair-Bejo M, Haghani A and Ideris A 2014 Mechanisms of action and efficacy of statins against influenza. Biomed. Res. Int. 2014 872370
Mukherjee S, Singh N, Sengupta N, Fatima M, Seth P et al. 2017 Japanese encephalitis virus induces human neural stem/progenitor cell death by elevating GRP78, PHB and hnRNPC through ER stress. Cell Death. Dis. 8 e2556
Nazmi A, Dutta K and Basu A 2011 RIG-I mediates innate immune response in mouse neurons following Japanese encephalitis virus infection. PLoS One 6 e21761
Nazmi A, Mukherjee S, Kundu K, Dutta K, Mahadevan A et al. 2014 TLR7 is a key regulator of innate immunity against Japanese encephalitis virus infection. Neurobiol. Dis. 69 235–247
Neuhaus O, Archelos JJ and Hartung HP 2003 Immunomodulation in multiple sclerosis: from immunosuppression to neuroprotection. Trends Pharmacol. Sci. 24 131–138
Niimi Y and Levison SW 2018 Pediatric brain repair from endogenous neural stem cells of the subventricular zone. Pediatr. Res. 83 385–396
Schweitzer BK, Chapman NM and Iwen PC 2009 Overview of the Flaviviridae with an emphasis on the Japanese encephalitis group viruses. Lab. Med. 40 493–499
Seyfried D, Han Y, Lu D, Chen J, Bydon A, et al. 2004 Improvement in neurological outcome after administration of atorvastatin following experimental intracerebral hemorrhage in rats. J. Neurosurg. 101 104–107
Shih RH, Wang CY and Yang CM 2015 NF-kappaB signaling pathways in neurological inflammation: a mini review. Front. Mol. Neurosci. 8 77
Song G, Ouyang G and Bao S 2005 The activation of Akt/PKB signaling pathway and cell survival. J. Cell. Mol. Med. 9 59–71
Sparks DL, Connor DJ, Browne PJ, Lopez JE and Sabbagh MN 2002 HMG-CoA reductase inhibitors (statins) in the treatment of Alzheimer’s disease and why it would be ill-advise to use one that crosses the blood-brain barrier. J. Nutr. Health. Aging. 6 324–331
Storer MA, Gallagher D, Fatt MP, Simonetta JV, Kaplan DR, et al. 2018 Interleukin-6 regulates adult neural stem cell numbers during normal and abnormal post-natal development. Stem. Cell. Rep. 10 1464–1480
Szybińska A and Leśniak W 2017 P53 Dysfunction in neurodegenerative diseases - the cause or effect of pathological changes? Aging Dis. 8 506–518
Turtle L and Solomon T 2018 Japanese encephalitis - the prospects for new treatments. Nat. Rev. Neurol. 14 298–313
Wang KW, Wang HK, Chen HJ, Liliang PC, Liang CL, et al. 2014 Simvastatin combined with antioxidant attenuates the cerebral vascular endothelial inflammatory response in a rat traumatic brain injury. Biomed. Res. Int. 2014 910260
Wang S, Liu Y, Guo J, Wang P, Zhang L, et al. 2017 Screening of FDA-approved drugs for inhibitors of Japanese encephalitis virus infection. J. Virol. 91 e01055–17
Acknowledgements
The study is supported by research grant to AB form Department of Biotechnology (BT/PR27796/Med/29/1301/2018). AB is also the recipient of Tata Innovation Fellowship (BT/HRD/35/01/02/2014). SM (Mallick) is also recipient of grant from Science & Engineering Research Board (SERB) (PDF/2016/000440). The authors sincerely acknowledge the help of Kanhaiya Lal Kumawat and Manish Dogra.
Author information
Authors and Affiliations
Corresponding author
Additional information
Corresponding editor: Saumitra Das
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Wani, M.A., Mukherjee, S., Mallick, S. et al. Atorvastatin ameliorates viral burden and neural stem/progenitor cell (NSPC) death in an experimental model of Japanese encephalitis. J Biosci 45, 77 (2020). https://doi.org/10.1007/s12038-020-00052-3
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s12038-020-00052-3